@article{333bcb125df44e9593a02cc7e611e17b,
title = "Pityriasis Rubra Pilaris Transcriptomics Implicate T Helper 17 Signaling and Correlate with Response to Ixekizumab, with Distinct Gene Expression Profiles in Nonresponders",
author = "Dylan Haynes and Taylor Reiter and Rose Velasco and Matthew Chang and Rajan Kulkarni and Gail Kent and Jennifer Strunck and Pamela Cassidy and Greiling, {Teri M.}",
note = "Funding Information: This study was funded by an investigator-initiated grant from Eli Lilly and Company. The funder had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and decision to submit the manuscript for publication. Data storage through REDCap was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under award No. UL1TR0002369. Funding Information: TMG has received research funding to study pityriasis rubra pilaris from Eli Lilly and Co for this study; has funding from Janssen Scientific Affairs to study unrelatd aspects of pityriasis rubra pilaris; and is an author for UpToDate on pityriasis rubra pilaris. The remaining authors state no conflict of interest. ",
year = "2023",
month = mar,
doi = "10.1016/j.jid.2022.09.005",
language = "English (US)",
volume = "143",
pages = "501--504.e1",
journal = "Journal of Investigative Dermatology",
issn = "0022-202X",
publisher = "Nature Publishing Group",
number = "3",
}